<bill session="117" type="s" number="4351" updated="2022-12-29T17:33:53Z">
  <state datetime="2022-06-06">REFERRED</state>
  <status>
    <introduced datetime="2022-06-06"/>
  </status>
  <introduced datetime="2022-06-06"/>
  <titles>
    <title type="display">Enhanced Access to Affordable Medicines Act of 2022</title>
    <title type="short" as="introduced">Enhanced Access to Affordable Medicines Act of 2022</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act to clarify the conditions under which the Secretary of Health and Human Services can approve generic drug applications with labeling temporarily different than the brand name drug, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="R000615"/>
  <cosponsors>
    <cosponsor bioguide_id="H001076" joined="2022-06-06"/>
    <cosponsor bioguide_id="H000273" joined="2022-06-06"/>
    <cosponsor bioguide_id="R000608" joined="2022-06-06"/>
  </cosponsors>
  <actions>
    <action datetime="2022-06-06">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-06-06" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="6973" relation="unknown"/>
    <bill session="117" type="h" number="7667" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-18T14:59:49Z" status="Introduced in Senate">Enhanced Access to Affordable Medicines Act of 2022

This bill specifies that the Food and Drug Administration may approve generic drugs with different labels than the brand-name versions if, among other requirements, a revised label for the brand-name drug is approved within 90 days of when the generic is otherwise eligible for approval.</summary>
</bill>
